Complementary and Alternative Medicine Methods Used for Sleep Disturbance in Menopause
PDF
Cite
Share
Request
Original Article
P: 207-213
September 2020

Complementary and Alternative Medicine Methods Used for Sleep Disturbance in Menopause

J Turk Sleep Med 2020;7(3):207-213
1. University of Health Sciences Turkey Hamidiye Faculty of Health Sciences, Department of Obstetrics, İstanbul, Turkey
2. Gümüşhane University Faculty of Health Sciences, Department of Obstetrics, Gümüşhane, Turkey
No information available.
No information available
Received Date: 20.06.2020
Accepted Date: 16.08.2020
Publish Date: 05.10.2020
PDF
Cite
Share
Request

ABSTRACT

Objective:

One of the most common complaints observed during the menopausal period is sleep disorders, affecting 40%-60% women. In this study, we aimed to determine complementary and clternative medicine (CAM) for menopausal women experiencing sleep disturbances, and the prevalence and influencing factors of sleep disturbance.

Materials and Methods:

In this descriptive cross-sectional study, we included menopausal women experiencing sleeplessness [≥4 degree of discomfort according to the Visual Analog Scale (VAS)] (n=201). A questionnaire and the CAM Scale were used to collect data. The necessary institutional and ethical committee permissions were obtained.

Results:

The mean age of the menopausal women was 47.23±4.53 [minimum (min)- maximum (max), 30-60] years, and their mean VAS for insomnia was 5.20±1.12 (min-max, 4-9). The following methods were used by the women to overcome insomnia: herbal supplements (96.6%), dietary supplements (98.8%), religious practices (95.7%), and mind-body practices (76.9%). The most common methods were fruits and vegetables, milk and dairy products, honey, linden tea, rosehip, prayer, pray, and music. Approximately 70.5% women expressed that the method they used was effective.

Conclusion:

Almost all menopausal women used any method of CAM. Further studies on the effectiveness of these methods as well as the training to be provided and the information dissemination by healthcare professionals are recommended.

Keywords: Menopause, Sleep disturbance, Complementary and alternative medicine

Introduction

Menopause is a natural biological process where estrogen levels decrease, and the menstrual cycle stops as a result of the depletion of egg follicles. Natural menopause age varies between 40 and 58, and the average age is 51 (1). Especially as a result of fluctuations in estrogen level and gradual decrease menopause symptoms start to be seen such as hot flashes and night sweats 36-87%, sleep problems 40-60%, palpitations 44-50%, weight gain 60-70%, muscle and joint pain 48-72%, headache 32-71%, memory loss 41-44%, mood change 15-78%, sexual dysfunction 20-30% (2-4).

One of the most common complaints observed in the menopausal period is sleep disorders and affects 40 to 60% of women (5). Age, socio-economic and business-related factors, chronic diseases, depression, mood disorders, hormonal fluctuations and symptoms related to menopause causes women to experience sleep problems during menopause (6,7). It is also noted that there is a correlation between the complaints of hot flashes and sleep problems, especially a strong correlation between night sweats and waking up (2). The most common sleep complaints during menopause are waking up at night and having difficulty falling asleep again (8).

Quality of life, healthy living behaviors, work efficiency, mood and physical health of women are adversely affected as a result of sleep disorders, and thus health service use is increasing. Besides, it has long-term effects on health and well-being (2,9). It has been reported that poor sleep quality and insufficient sleep time are associated with adverse health outcomes such as obesity, cardiovascular diseases, cancer-related deaths, diabetes, depression. For this reason, it is important for women’s health to identify the sleep disorders and related risk factors of women in the menopause period and to cure properly (10).

It is recommended that hormone therapy be used at a minimum level in the short term to reduce symptoms (11,12). However, there is an opinion polarization about hormone therapy worldwide according to heart and estrogen/progestin replacement (13), Women’s Health Initiative (14), Trial and Million Women Study (15) publications. The Scientific Advisory Committee of the Royal College of Obstetricians and Gynecologists recommended non-drug treatments to reduce menopausal symptoms in 2006. Especially recently, the use of complementary and alternative treatment of non-pharmacological methods for insomnia problems is preferred (16).

This study was designed to determine the complementary and alternative treatments that women in the menopause period receive for sleep disturbances, the frequency, and the affecting factors.

Setting and Sample

The study is descriptive and cross-sectional. The research population is composed of women applied to a public hospital polyclinic (internal medicine, gynecology) between 15.02.2018/15.06.2018 and the sample unit is composed of 201 women accepted to take part voluntarily in the study. The suitability of the data and the adequacy of the sample size were examined with the Kaiser-Meyer-Olkin (KMO) coefficient and Bartlett’s Test of Sphericity. KMO values of 0.80 and above are excellent, values between 0.70-0.80 are good, values between 0.60-0.70 are moderate, values between 0.50-0.60 are bad, and values below 0.50 are unacceptable (17). In this study, KMO coefficient of Complementary and Alternative Medicine Scale (CAMS) was found 0.787 (good).

Inclusion and Exclusion Criteria

The study included women who were in the menopausal period by their declarations, who had not menstruated for the past one year and had complaints of insomnia [who reported complaints of 4 or more complaints according to the Visual Analog Scale (VAS)]. The VAS scale consists of sequential numbers from 0 to 10. Number 0 refers to “no complaints at all”, and number 10 implies “complaints are the most severe”. It was not included in the study in the case that women did not agree to take part in the study and had cognitive problems. A total of 112 women in the menopausal period without sleep problems were excluded from the study.

Data Collection Tools

The data forms of the research were created in accordance with the literature review. A questionnaire including socio-demographic characteristics of women, information about the menopausal period and sleep disturbance, and CAMS were used.

Complementary and Alternative Medicine scale: CAMS was developed by Can et al. (18) The scale consists of five subgroups of 55 CAM interventions frequently used. The five subgroups comprise the following; including the biological practices subgroup (3 items), herbal supplement subgroup (29 items), mind-body practices subgroup (5 items), religious practices subgroup (5 items) and dietary supplement subgroup (14 items). CAMS assesses the use of individual CAM methods by dichotomous responses, where 1 means “yes” and 0 means “no”. Sub-dimension scores were calculated summing up the scores of individual items and the total score of the scale is the sum of individual sub-dimension scores. The Kuder-Richardson 20 (KR20) coefficient for the scale was 0.84 (18).

Ethical Considerations

The required permission to conduct the study was obtained from the administration unit of the Health Directorate and from the Scientific Research and Publication Board of Gümüşhane University (Number: 95674917-604.01.02-E.6100). Eligible women were informed about the study. Verbal consent was obtained from women, who accepted to participate in the study. Each woman was interviewed for 20 minutes to fill in the data collection questionnaire.

Statistical Analysis

Descriptive statistics, median, mean, frequency and percentages were used for summarizing the distribution of women features and characteristics of menopause. The Mann-Whitney U and Kruskal-Wallis tests were used in the assessment of factors affecting CAM use. All statistical tests were two-sided and the significance level was set at 0.05.

Results

The socio-demographic characteristics of women are shown in Table 1. 81.1% of women with a mean age of 54.53±6.02 [minimum (min)-maximum (max)=35-65] were the housewife, 47.3% of them were high-school graduate and postgraduate, and 84.6% were married. The average age of women in menopause was 47.23±4.53 (min-max=30-60), and the average of complaints of insomnia according to VAS was 5.20±1.12 (min-max=4-9).

Table 1

According to the research, 9% of women were smoking, 33.3% were consuming 1 or 2 cups of coffee per day. 73% of the women were overweight and obese group, their average Body Mass Index (BMI) was 27.7±4.49 (min-max=19-43). 61.2% of women had a chronic disease (such as hypertension, diabetes, asthma), and 21.4% of them have a constant drug.

In this study, 6% of the women surgically and 3% went through early menopause (below 40 years old). The mean VAS score of insomnia in women surgically went through menopause is 5.25, and the mean of VAS for those who went through early menopause is 6.1. 53.5% of women have knowledge of the menopausal period. Doctor-nurse (27.4%), the circle of friends (38.3%) and TV-media (11.4%) were determined as the source of information. 59.8% of the women expressed that they got alternative treatment for sleep problems (such as herbal treatment, exercise, massage, aromatherapy, yoga). 70.5% of women stated that the method they used worked. 66.2% of the women began to have an alternative treatment by hearing from the environment, 18.2% from the nurses, 9.1% from the doctor and 6.1% from social media. 14.9% of women used drugs for their sleep problems by applying for a doctor. Women’s problems with insomnia were presented in Table 2.

Table 2

It was determined that the complaints began in the premenopausal period (in the first year of menopause) for half of the women suffering from sleep complaints. About half of women stated that they had a problem to fall asleep in 15 minutes, more than half of them had complaints once or two times a week. It was found that 81.1% of women affected by their daily life activities due to sleep problems and 87.5% of women whose daily life affected received medical treatment (Table 2). In addition, all women have tried different methods for their sleep problems. CAM practices used by women for their sleep problems in menopause were given in Table 3.

Table 3

It was found that the use of CAM for women experiencing sleep problems in menopause was quite common (96.6% of them were herbal, 98.8% were nutritional, 95.7% were religious and 76.9% of them were mental approaches) and they did not prefer only biological methods. Comparison of sub-dimension and total score averages of CAM scale according to characteristics of the participants is given in Table 4.

Table 4

As a result of the analysis of some characteristics of the participants with the CAM Score averages, no significant differences were found between the contagion to the daily life, income status, information about the menopausal period, where the information was taken and the presence of chronic disease. However, those who did not receive any information about the menopause period, those who did not have a chronic disease, and whose education status was low and income status was higher had higher mean scores. CAM Scale scores were lower for those whose daily life activities were affected.

As a result of the analysis, the use of CAM methods was more common for people who didn’t smoke, who didn’t drink coffee during the day, who had normal weight according to BMI, who didn’t receive any medical help for their menopause complaints, who had more frequent complaints of insomnia.

Discussion

The mean age of women in the study was 55 and the mean age of menopause was 47. Although menopausal age varies according to countries, the findings were similar to other studies. While the age of menopause in the developed countries is between 49.3 and 51.4, it is between 43.5 and 49.4 in the developing countries. For example, the average age of menopause in Jordan is 50-51, 47 in Turkey, 48 in Egypt and The United States is also reported to be 51-52 years old (19-21).

The average of insomnia complaints among women took part in the study is 5.2 according to VAS and is besetting at a moderate level. Studies have also shown that the insomnia problems during the menopausal period are disturbing and affect the quality of life of women (22,23).

According to the research, 6% of women surgically went through menopause and 3% went through early menopause. The most frequent complaints of insomnia were seen among the women who had early menopause, and secondly among the women surgically went through menopause. In addition, half of the women experienced a more acute complaint in the premenopausal period. The Study of Women’s Health Across the Nation reported that 38% of women aged 40-55 years had sleep problems, this rate increased after perimenopausal (45.4%), and surgical postmenopause (47.6%) (8). Similarly, The Wisconsin Sleep Cohortuna, which resembles our study, reported that premenopausal women’s sleep complaints are twice as much as perimenopause and postmenopausal women. In the study of Jehan, it was also reported that the prevalence of sleep disorder ranged from 39% to 47% in perimenopause, and 35% to 60% in postmenopause (24).

About half of women who suffer from insomnia to fall asleep within 15 minutes and almost all of them uses different methods to overcome sleep problems. It was found that one-quarter of the women had complaints every day and the life quality of the majority of women deteriorated. In a study, 25% of perimenopausal women and 30% of postmenopause women reported having a good night’s sleep only a few nights in a month or less (22,23).

About half of women had knowledge of the menopausal period and only one-fourth of them received information from their health care providers about the period. 70% of women who used CAM also expressed that the method was effective. In studies, it was found that women in the menopausal periods did not prefer hormone therapies and antidepressants for sleep problems due to their adverse side effects. For these reasons, women tend towards alternative and complementary treatments (23,25). In particular, herbal treatments such as black bugbane (26), omega-3 (27), valerian (28), isoflavone (29) and dietary supplements are popular methods preferred by women for sleep problems. It is noted that non-pharmacological methods such as acupuncture, awareness, reflexology, exercise, and yoga are preferred recently, and more studies are needed (30,31). In our study, it was found that women used many CAM methods for their sleep problems the most preferred methods are Religious practices [prayer (89.1%), pray (86.6%)]. Dietary supplements [yoghurt (74.6%), milk and milk products (68.7), honey (68.2), fruits and vegetables (87.6%)], herbal supplements [linden tea (67.2%), rosehip (57.7%), green tea (45.3%), nigella sativa (41.8%), thyme (43.3%), daisy (43.3%)], mind-body practices [music (38.3%), exercise (9.8%)]. It is more common CAM to be used among those who do not have a knowledge of the menopausal period, do not have a chronic disease, do not smoke, do not drink coffee, do not receive medical aid, and those with low-educational status, with high-income, and with normal weight. It was also stated that poor sleep quality during menopause was higher among women with low education and low income in the study of Kim et al. (10).

Conclusion

Sleep problem is one of the common disorders that women face throughout their lives. It is also commonly seen in physiological changes such as menopause. Poor quality of sleep affects women’s daily life activities. Women prefer alternative and complementary treatments rather than medical therapies for the treatment of sleep problems. The present study found that almost all women with sleep problems during the menopausal period used CAM and started without any training or knowledge. The effectiveness of these methods should be investigated more comprehensively, the education for women in menopause should be given by health professionals and the education should be generalized. The limitation of the study was that sleep was not assessed by a structured instrument. In addition, it is recommended to carry out far-reaching studies where sleep is evaluated with applications such as actigraphy.

References

1
Marlatt K, Beyl RA, Redman LM. A qualitative assessment of health behaviors and experiences during menopause: a cross-sectional, observational study. Maturitas 2018;116:36-42.
2
Baker FC, Lampio L, Saaresranta T, Polo-Kantola P. Sleep and Sleep Disorders in the Menopausal Transition. Sleep Med Clin 2018;13:443-56.
3
Nelson HD. Menopause. Lancet 2008;371:760-70.
4
Santoro N. Perimenopause: from research to practice. J Womens Health (Larchmt) 2016;25:332-9.
5
Xu Q, Lang CP. Examining the relationship between subjective sleep disturbance and menopause: a systematic review and meta-analysis. Menopause 2014;21:1301-18.
6
Cheng MH, Hsu CY, Wang SJ, Lee SJ, Wang PH, Fuh JL. The relationship of self-reported sleep disturbance, mood, and menopause in a community study. Menopause 2008;15:958-62.
7
Cuadros JL, Fernández-Alonso AM, Cuadros-Celorrio AM, Fernández-Luzón N, Guadix-Peinado MJ, del Cid-Martín N, Chedraui P, Pérez-López FR; MenopAuse Risk Assessment (MARIA) Research Group. Perceived stress, insomnia and related factors in women around the menopause. Maturitas 2012;72:367-72.
8
Kravitz HM, Zhao X, Bromberger JT, Gold EB, Hall MH, Matthews KA, Sowers MR. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep 2008;31:979-90.
9
Shaver JL, Woods NF. Sleep and menopause: A narrative review. Menopause 2015;22:899-915.
10
Kim MJ, Yim G, Park HY. Vasomotor and physical menopausal symptoms are associated with sleep quality. PLoS ONE 2018;13:e0192934.
11
Unni J. Third consensus meeting of Indian Menopause Society 2008: A summary. J Midlife Health 2010;1:43-7.
12
Mishra N, Mishra VN, Devanshi. Quinquagenarian women and Hormone Therapy-The Changing Scenario. Int J Gynaecol Obstet India 2011;14:91-6.
13
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post menopausal women. JAMA 2002;280:605-13.
14
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women; principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
15
Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-27.
16
Tal JZ, Suh SA, Dowdle CL, Nowakowski S. Treatment of Insomnia, Insomnia Symptoms, and Obstructive Sleep Apnea During and After Menopause: Therapeutic Approaches. Curr Psychiatry Rev 2015;11:63-83.
17
Durmus B, Yurtkori S, Cinko M. Data Analysis with SPSS in Social Sciences. Istanbul, Beta Publishing 2013;80.
18
Can G, Erol O, Aydiner A, Topuz E. Quality of life and complementary and alternative medicine use among cancer patients in Turkey. Eur J Oncol Nurs 2009;13:287-94.
19
Gharaibeh M, Al-Obeisat S, Hattab J. Severity of menopausal symptoms of Jordanian women. Climacteric 2010;13:385-94.
20
Özcan H, Oskay Ü. Evidence based symptoms management in menopause. Göztepe Medical Journal 2013;26:157-63.
21
Shifren JL, Gass ML; NAMS Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women. Manopause 2014;21:1038-62.
22
Baker FC, Wolfson AR, Lee KA. Association of sociodemographic, lifestyle, and health factors with sleep quality and daytime sleepiness in women: findings from the 2007 National Sleep Foundation “Sleep in America Poll”. J Womens Health (Larchmt) 2009;18:841-9.
23
Nowakowski S, Meers J, Heimbach E. Sleep and Women’s Health. Sleep Med Res 2013;4:1-22.
24
Jehan S, Masters-Isarilov A, Salifu I, Zizi F, Jean-Louis G, Pandi-Perumal SR, Gupta R, Brzezinski A, McFarlane SI. Sleep disorders in postmenopausal women. J Sleep Disord Ther 2015;4:1-7.
25
Joffe H, Petrillo L, Viguera A, Koukopoulos A, Silver-Heilman K, Farrell A, Yu G, Silver M, Cohen LS. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial. Am J Obstet Gynecol 2010;202:171.
26
Vermes G, Banhidy F, Acs N. The effects of remifemin on subjective symptoms of menopause. Adv Ther 2005;22:148-54.
27
Cohen LS, Joffe H, Guthrie KA, Ensrud KE, Freeman M, Carpenter JS, Learman LA, Newton KM, Reed SD, Manson JE, Sternfeld B, Caan B, Freeman EW, LaCroix AZ, Tinker LF, Booth-Laforce C, Larson JC, Anderson GL. Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause 2014;21:347-54.
28
Taavoni S, Nazem Ekbatani N, Haghani H. Valerian/lemon balm use for sleep disorders during menopause. Complement Ther Clin Pract 2013;19:193-6.
29
Hachul H, Brandao LC, D’Almeida V, Bittencourt LR, Baracat EC, Tufik S. Isoflavones decrease insomnia in postmenopause. Menopause 2011;18:178-84. (PubMed: 20729765)
30
Carmody JF, Crawford S, Salmoirago-Blotcher E, Leung K, Churchill L, Olendzki N. Mindfulness training for coping with hot flashes: results of a randomized trial. Menopause 2011;18:611-20.
31
Asltoghiri M, Ghodsi Z. The effects of Reflexology on sleep disorder in menopausal women. Procedia- Social and Behavioral Sciences 2012;31:242-6.
2024 ©️ Galenos Publishing House